339 related articles for article (PubMed ID: 10338003)
21. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas.
Hadfield KD; Smith MJ; Urquhart JE; Wallace AJ; Bowers NL; King AT; Rutherford SA; Trump D; Newman WG; Evans DG
Oncogene; 2010 Nov; 29(47):6216-21. PubMed ID: 20729918
[TBL] [Abstract][Full Text] [Related]
22. [Neurofibromatosis type 2 (NF2)].
Araki N; Takeshima H; Saya H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
[TBL] [Abstract][Full Text] [Related]
23. Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors.
Wolff RK; Frazer KA; Jackler RK; Lanser MJ; Pitts LH; Cox DR
Am J Hum Genet; 1992 Sep; 51(3):478-85. PubMed ID: 1496981
[TBL] [Abstract][Full Text] [Related]
24. Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus.
Sanson M; Marineau C; Desmaze C; Lutchman M; Ruttledge M; Baron C; Narod S; Delattre O; Lenoir G; Thomas G
Hum Mol Genet; 1993 Aug; 2(8):1215-20. PubMed ID: 8401504
[TBL] [Abstract][Full Text] [Related]
25. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.
Ueki K; Wen-Bin C; Narita Y; Asai A; Kirino T
Cancer Res; 1999 Dec; 59(23):5995-8. PubMed ID: 10606247
[TBL] [Abstract][Full Text] [Related]
26. Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas.
Lomas J; Bello MJ; Arjona D; Alonso ME; Martinez-Glez V; Lopez-Marin I; Amiñoso C; de Campos JM; Isla A; Vaquero J; Rey JA
Genes Chromosomes Cancer; 2005 Mar; 42(3):314-9. PubMed ID: 15609345
[TBL] [Abstract][Full Text] [Related]
27. [Development and establishment of a yeast-based stop codon assay for detection of NF2 gene premature-terminating mutations].
Kobayashi H
Hokkaido Igaku Zasshi; 1999 Sep; 74(5):377-86. PubMed ID: 10495852
[TBL] [Abstract][Full Text] [Related]
28. The neurofibromatosis 2 (NF2) tumour suppressor gene: implications beyond the hereditary tumour syndrome?
Kley N; Seizinger BR
Cancer Surv; 1995; 25():207-18. PubMed ID: 8718520
[TBL] [Abstract][Full Text] [Related]
29. [Molecular biological analysis of neurofibromatosis type 2 gene].
Ichimura K; Yuasa Y
Nihon Rinsho; 1993 Sep; 51(9):2462-6. PubMed ID: 8411729
[TBL] [Abstract][Full Text] [Related]
30. Mapping the breakpoint of a constitutional translocation on chromosome 22 in a patient with NF2.
Arai E; Tokino T; Imai T; Inazawa J; Ikeuchi T; Tonomura A; Nakamura Y
Genes Chromosomes Cancer; 1993 Apr; 6(4):235-8. PubMed ID: 7685627
[TBL] [Abstract][Full Text] [Related]
31. Frequent mutations of NF2 and allelic loss from chromosome band 22q12 in malignant mesothelioma: evidence for a two-hit mechanism of NF2 inactivation.
Cheng JQ; Lee WC; Klein MA; Cheng GZ; Jhanwar SC; Testa JR
Genes Chromosomes Cancer; 1999 Mar; 24(3):238-42. PubMed ID: 10451704
[TBL] [Abstract][Full Text] [Related]
32. Progress towards the isolation and characterization of the genes causing neurofibromatosis.
Menon AG; Gusella JF; Seizinger BR
Cancer Surv; 1990; 9(4):689-702. PubMed ID: 2129297
[TBL] [Abstract][Full Text] [Related]
33. Somatic instability of the NF2 gene in schwannomatosis.
Kaufman DL; Heinrich BS; Willett C; Perry A; Finseth F; Sobel RA; MacCollin M
Arch Neurol; 2003 Sep; 60(9):1317-20. PubMed ID: 12975302
[TBL] [Abstract][Full Text] [Related]
34. Sensitive detection of deletions of one or more exons in the neurofibromatosis type 2 (NF2) gene by multiplexed gene dosage polymerase chain reaction.
Diebold R; Bartelt-Kirbach B; Evans DG; Kaufmann D; Hanemann CO
J Mol Diagn; 2005 Feb; 7(1):97-104. PubMed ID: 15681480
[TBL] [Abstract][Full Text] [Related]
35. The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2.
Baser ME; Kuramoto L; Woods R; Joe H; Friedman JM; Wallace AJ; Ramsden RT; Olschwang S; Bijlsma E; Kalamarides M; Papi L; Kato R; Carroll J; Lázaro C; Joncourt F; Parry DM; Rouleau GA; Evans DG
J Med Genet; 2005 Jul; 42(7):540-6. PubMed ID: 15994874
[TBL] [Abstract][Full Text] [Related]
36. Multiple meningiomas: differential involvement of the NF2 gene in children and adults.
Evans DG; Watson C; King A; Wallace AJ; Baser ME
J Med Genet; 2005 Jan; 42(1):45-8. PubMed ID: 15635074
[TBL] [Abstract][Full Text] [Related]
37. Progress toward the isolation and characterization of the genes causing neurofibromatosis.
Menon AG; Gusella JF; Seizinger BR
Brain Pathol; 1990 Sep; 1(1):33-40. PubMed ID: 1669691
[TBL] [Abstract][Full Text] [Related]
38. Intrafamilial correlation of clinical manifestations in neurofibromatosis 2 (NF2).
Zhao Y; Kumar RA; Baser ME; Evans DG; Wallace A; Kluwe L; Mautner VF; Parry DM; Rouleau GA; Joe H; Friedman JM
Genet Epidemiol; 2002 Oct; 23(3):245-59. PubMed ID: 12384977
[TBL] [Abstract][Full Text] [Related]
39. Neurofibromatosis type 2 appears to be a genetically homogeneous disease.
Narod SA; Parry DM; Parboosingh J; Lenoir GM; Ruttledge M; Fischer G; Eldridge R; Martuza RL; Frontali M; Haines J
Am J Hum Genet; 1992 Sep; 51(3):486-96. PubMed ID: 1496982
[TBL] [Abstract][Full Text] [Related]
40. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas.
Ruttledge MH; Sarrazin J; Rangaratnam S; Phelan CM; Twist E; Merel P; Delattre O; Thomas G; Nordenskjöld M; Collins VP
Nat Genet; 1994 Feb; 6(2):180-4. PubMed ID: 8162072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]